Bluestein R H & CO LLC Boston Scientific Corp Transaction History

Bluestein R H & CO LLC

$1.61 Billion
Q3 2022

A detailed history of Bluestein R H & CO LLC transactions in Boston Scientific Corp stock. As of the latest transaction made, Bluestein R H & CO LLC holds 24,000 shares of BSX stock, worth $2.16 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

24,000

Previous 24,050 0.21%

Holding current value

$2.16 Million

Previous $896,000 3.79%

% of portfolio

0.06%

Previous 0.06%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$36.71 - $109.66 $1,835 - $5,483	-50 Reduced 0.21%	24,000 $930,000
Q2 2021 Aug 13, 2021	SELL	$38.58 - $44.24 $5,787 - $6,636	-150 Reduced 0.62%	24,050 $1.03 Million
Q3 2020 Nov 12, 2020	SELL	$34.44 - $42.23 $3,444 - $4,223	-100 Reduced 0.41%	24,200 $925,000
Q2 2020 Aug 12, 2020	SELL	$30.19 - $39.11 $141,893 - $183,817	-4,700 Reduced 16.21%	24,300 $853,000
Q1 2020 May 12, 2020	BUY	$25.83 - $45.71 $129,149 - $228,550	5,000 Added 20.83%	29,000 $946,000
Q4 2019 Feb 13, 2020	SELL	$37.87 - $45.37 $18,935 - $22,685	-500 Reduced 2.04%	24,000 $1.09 Million
Q4 2018 Feb 13, 2019	SELL	$31.73 - $39.04 $317,300 - $390,400	-10,000 Reduced 28.99%	24,500 $866,000
Q3 2018 Nov 13, 2018	SELL	$32.83 - $38.63 $234,734 - $276,204	-7,150 Reduced 17.17%	34,500 $1.33 Million
Q2 2018 Aug 10, 2018	BUY	$26.84 - $34.32 $4,026 - $5,148	150 Added 0.36%	41,650 $1.36 Million
Q1 2018 May 10, 2018	BUY	$25.2 - $28.54 $289,800 - $328,210	11,500 Added 38.33%	41,500 $1.13 Million
Q4 2017 Feb 13, 2018	SELL	$24.79 - $29.8 $1.21 Million - $1.46 Million	-48,900 Reduced 61.98%	30,000 $744,000
Q3 2017 Nov 13, 2017	BUY	$26.26 - $29.17 $2.07 Million - $2.3 Million	78,900	78,900 $2.3 Million

Others Institutions Holding BSX

# of Institutions

1,539

Shares Held

1.19B

Call Options Held

6.79M

Put Options Held

10.1M

View Full List

About BOSTON SCIENTIFIC CORP

Ticker BSX
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,431,609,984
Market Cap $129B
Description
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...

More about BSX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bluestein R H & CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bluestein R H & CO LLC with notifications on news.

Account

Bluestein R H & CO LLC Boston Scientific Corp Transaction History